Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Sunpeaks Ventures, Inc. (OTCBB: SNPK) Featured By Small Cap Investment Research

(EMAILWIRE.COM, April 11, 2012 ) Los Angeles, CA -- Small Cap Investment Research (SmallCapInvestmentResearch.com), a developer, publisher and marketer of independent research products, announced today the release of an updated research report on Sunpeaks Ventures, Inc (OTCBB: SNPK) (“the Company”). Small Cap Investment Research has issued a “STRONG BUY” and a target price of $9.00 on shares of this company.



The report examines the potential continued growth of the Company as it continues to gain market share, and examines the outlook for short and long-term investors. “We were pleased to have the opportunity to report on this company and the industry factors that affect it. The report presents a great overview of the Company and its potential for the long-term with a constantly improving industry dynamic.” – Small Cap Investment Research.



Recently, Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") announced that HDS has signed a Letter of Intent with PharmaLife® for placement of Clotamin® with leading pharmacies in the Russian Federation.



The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma. PharmaLife is also expected to secure timely product registration within the Russian Federation for Clotamin distribution and conduct local market research to support a successful product launch.

The entire report can be found on http://www.smallcapinvestmentresearch.com/featured-companies/ .



About Small Cap Investment Research:

Small Cap Investment Research specializes in providing readers with an in-depth analysis of undervalued companies. The company’s role as an independent research analyst firm is to “separate the wheat from the chaff” and help investors receive unbiased, thought-provoking, and quality investment research. SCIR’s philosophy in research is to encapsulate realistic investment ratings, target prices, and forward-looking financial models. The reports contain hard-hitting, meticulously researched facts on companies, their fundamentals, and their industries, validating a company’s prospects and enabling the reader to objectively evaluate the company’s value. The media and savvy investors alike view this model as how investment research needs to be performed devoid of any partiality.



About Sunpeaks Ventures, Inc.:

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.



Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Sunpeaks Ventures, Inc. (OTCBB: SNPK) can be found in the filings of Sunpeaks Ventures, Inc. with the U.S. Securities and Exchange Commission.



Release of Liability: Through use of this website viewing or using you agree to hold SCIR, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We have been compensated six thousand dollars for this SNPK report. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCIR encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCIR makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.



Indepedent Research Investment
Derrick Brazinski
3104567798
dbrazinski@indedentresearchinvestment.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Cheaper biosimilars take aim at world's top medicines
5 Mar 2015 at 11:05pm
(Reuters) - Lower-cost versions of biological drugs, known as biosimilars, are taking aim at some of the world's biggest-selling medicines.     Unlike chemical compounds, such as aspirin or statins, these biotech products are made of hormones, antibodies and other proteins. SEVEN OUT OF 10 TOP DRUGS ARE BIOLOGICAL The proliferation of potent biological drugs, coupled with price tags that run into tens of thousands of dollars per patient a year, means they now account for around 30 percent of U.S. and European drug spending.

Copy me: Europe shows U.S. a path to cheaper biotech drugs
5 Mar 2015 at 11:03pm
By Ben Hirschler and Deena Beasley LONDON/LOS ANGELES (Reuters) - A revolution is brewing in healthcare with lower-cost copies of complex biotech drugs finally set to reach the United States, nine years after so-called biosimilars were launched in Europe. The first approval for a biosimilar in the United States is expected imminently - Zarxio, Novartis' copy of Amgen's white blood cell-boosting product Neupogen. The conventional wisdom has been that such copycats, which are still far more difficult to make than standard chemical drugs, will sell at a modest discount of perhaps 20 to 30 percent to the original biotech brands.     Yet when Norway's drug procurement agency held its latest national hospital tender in January for a biosimilar copy of Johnson & Johnson and Merck's Remicade it was offered a whopping 69 percent discount to the original brand.     The decision to slash the price was made by Orion Pharma, which distributes the biosimilar known as Remsima in Norway for South Korea's Celltrion.


Liberia releases last known Ebola patient from care
5 Mar 2015 at 10:51pm

By James Harding Giahyue MONROVIA (Reuters) - Liberia's last Ebola patient left hospital on Thursday to cheers of delight from friends and family, a year after the West African country reported its first case. Liberia's capital, Monrovia, was once at the heart of an epidemic that has killed nearly 10,000 across West Africa. Liberia has reported no new Ebola cases in 13 days, but can be deemed Ebola-free only after 42 days have passed -- double the normal incubation period for the virus. Dressed in a bright orange T-shirt and multi-coloured beads, a joyous Beatrice Yardolo greeted a small crowd outside the Chinese Ebola treatment centre in the Paynesville suburb of Monrovia, where she was hospitalised for two weeks.


What kills more women than AIDS and breast cancer? Dirty wate
5 Mar 2015 at 8:59pm
By Maria Caspani NEW YORK (Thomson Reuters Foundation) - Diseases spread through dirty water and poor sanitation are the fifth biggest killer of women worldwide, causing more deaths than AIDS, diabetes or breast cancer, researchers say. Nearly 800,000 women die every year because they lack access to safe toilets and clean water, said the development organization WaterAid, which analyzed data from the Seattle-based Institute of Health Metrics research center. "This completely unacceptable situation affects women and girls' education, their health, their dignity and ultimately, in too many cases, results in an early and needless death," WaterAid CEO Barbara Frost said in a statement. The only conditions more fatal for women than the lack of decent sanitation are heart disease, stroke, lower respiratory infections and chronic obstructive pulmonary disease, according to the report.


Chain of kidney transplants begins at San Francisco hospital
5 Mar 2015 at 8:33pm

SAN FRANCISCO (AP) ? Zully Broussard thought she was going to help one person by donating a kidney.



U.S. says inaction on online piracy risks public safety
5 Mar 2015 at 7:11pm

By Krista Hughes WASHINGTON (Reuters) - The U.S. trade office on Thursday called for a crackdown on website name registrars who fail to take action against sellers of illegal goods such as counterfeit medicines and warned that turning a blind eye puts public safety at risk. The U.S. Trade Representative also said it is keeping an eye on China's Alibaba Group Holding Ltd's  consumer shopping website for sales of fake and pirated goods, but refrained from reinstating the site on its piracy blacklist. USTR named a domain name registrar, a company which manages the registration of internet names, for the first time in its annual "notorious markets" list as an example of concern about some registrars not taking action to block or suspend sites selling illegal goods. The registrar, Canada's Tucows Inc, said it took down dozen of sites every day but unlike some competitors, it considered all complaints carefully to ensure they were justified.


California 'maternity hotel' operators may face heat from guests
5 Mar 2015 at 5:39pm
By Steve Gorman LOS ANGELES (Reuters) - At least some of the pregnant women from China caught up in raids this week on so-called maternity hotels, catering to foreign mothers-to-be seeking U.S. citizenship for their babies, are still likely to remain long enough in California to give birth on American soil. Federal officials have declined to say how many pregnant customers they encountered in searches conducted on Tuesday of more than 50 locations suspected of involvement in three large "maternity tourism" networks in Southern California. No arrests have been made as of Thursday, said Virginia Kice, a spokeswoman for the U.S. Immigration and Customs Enforcement agency, or ICE. She declined to say how many if any of the women would end up staying long enough to give birth in the United States now that the schemes were exposed but suggested some were likely to remain in California as the investigation progresses.


Exclusive: Costco working to end use of human antibiotics in chicken
5 Mar 2015 at 4:25pm

By Nathan Layne CHICAGO (Reuters) - Costco Wholesale Corp is working toward eliminating the sale of chicken and meat from other animals raised with antibiotics that are vital to fighting human infections, senior executives at the third-largest U.S. retailer told Reuters on Thursday. The ongoing push by Costco, which sells 80 million rotisserie chickens a year, highlights growing pressure on the supply chain in the wake of this week's announcement by fast-food giant McDonald's Corp that it would stop buying chicken raised with so-called "shared-use" antibiotics within two years. "We are working towards, and working with our suppliers and the regulatory agencies... to see how we can get rid of shared-use antibiotics in animals," Craig Wilson, vice president of food safety at the Issaquah, Washington-based retail giant, said in a phone interview. "I think all of us want to move to a point where we can get the human-use antibiotics out of the system.



Opening statements in Colorado cinema massacre trial due April 21
5 Mar 2015 at 3:16pm

By Keith Coffman CENTENNIAL, Colo. (Reuters) - The judge overseeing the Colorado cinema massacre trial said on Thursday he wants opening statements in the much-delayed case against gunman James Holmes to begin on April 21. "We hope to have openings on April 21," Arapahoe County District Court Judge Carlos Samour told one prospective juror.


Report: Suicides by girls and young women continue to climb
5 Mar 2015 at 3:15pm
NEW YORK (AP) ? The suicide rate for girls and young women in the U.S. continues to rise, at a pace far faster than for young males, health officials said Thursday.

Washington state woman files wrongful death lawsuit over superbug infection
5 Mar 2015 at 2:51pm
By Victoria Cavaliere SEATTLE (Reuters) - A Washington state woman has filed a lawsuit against a hospital and a leading medical-device manufacturer claiming her husband died from a drug-resistant "superbug" he contracted from a contaminated medical scope, her lawyer said on Thursday. Theresa Bigler, of Woodway, is seeking unspecified monetary damages for the death of her husband Richard Bigler, 57, who died in 2013 after a battle with pancreatic cancer. Bigler's attorney, Joel Cunningham, said his death certificate also lists a drug-resistant form of E. coli bacteria as contributing to his demise. Bigler was among 31 people infected in an outbreak at Seattle's Virginia Mason Medical Center between 2012 and 2014 that was spread through medical devices called duodenoscopes that the hospital said harbor the germs even after being cleaned to manufacturer and federal guidelines.


U.S. third bitcoin auction spurs more demand with 34 bids
5 Mar 2015 at 2:49pm

By Gertrude Chavez-Dreyfuss NEW YORK (Reuters) - The U.S. Marshals Service on Thursday held its third auction of bitcoins seized from Ross Ulbricht, convicted of operating black-market website Silk Road, with a sale of 50,000 units attracting higher demand than the previous auction. The government had 14 registered bidders for the 34 bids received, said Marshals Service spokeswoman Lynzey Donahue. The bitcoins on the auction block are valued at $13.9 million at current prices. The six-hour online auction began at 8 a.m. EST (1300 GMT).



FDA study finds little evidence of antibiotics in milk
5 Mar 2015 at 2:46pm

WASHINGTON (AP) ? In an encouraging development for consumers worried about antibiotics in their milk, a new Food and Drug Administration study showed little evidence of drug contamination after surveying almost 2,000 dairy farms.


Inspector testing positive for deadly bacteria didn't get it at Louisiana lab...
5 Mar 2015 at 2:45pm
(Reuters) - A federal investigator who tested positive for a deadly bacteria that affected five monkeys at a Louisiana primate research facility did not contact it while she was at the lab, the U.S. Centers for Disease Control and Prevention said on Thursday. The worker likely became exposed to the bacteria, Burkholderia pseudomallei, during previous travels to parts of the world where the bacteria is endemic, Jason McDonald, a spokesman at the CDC, told Reuters. Five monkeys at the high-security Tulane National Primate Research Center near New Orleans were accidentally infected with or exposed to the bacteria late last year. Research on the bacteria, which was being done to find a vaccine, has been halted while investigators determine how the bacteria escaped from its confines in the lab, Tulane spokesman Mike Strecker said.

Many in U.S. live too far from advanced stroke care
5 Mar 2015 at 2:34pm
By Andrew M. Seaman (Reuters Health) - Many Americans would not have quick access to the best healthcare options during a stroke, even under the most ideal circumstances, according to a new computer model. ?There are effective treatments for stroke, but they are time sensitive,? said lead author Dr. Michael Mullen. ?The faster a patient is treated, the more likely they are to be eligible for acute stroke therapies and the more effective those therapies will be.? Timely transport to a qualified medical center is especially important with recent evidence supporting a new method to clear stroke-causing blood clots from the brain, said Mullen, a neurologist from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, in an email to Reuters Health. Starting in 2012, they could also be certified as comprehensive stroke centers to show they deliver the most advanced stroke care.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC